Business Standard

Marksans Pharma soars as UK MHRA finds no critical observations at Goa unit

The stock surged 20% to Rs 48.70 on the BSE in intra-day trade on back of heavy volumes.

Capsules
Premium

Capsules

SI Reporter Mumbai
Marksan Pharma surged 20% to Rs 49 on the BSE in intra-day trade after the company said UK health regulator has completed the inspection of Goa unit without any critical observations.

“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.

The same has been completed without any critical observations, it added.

The company said it is awaiting further instructions from the agency

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in